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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYOrganogenesis requires expansion of the embryonic vascular plexus thatmigrates into developing organs through a process called angio-
genesis. Mesodermal progenitors are thought to derive endothelial cells (ECs) that contribute to both embryonic vasculogenesis and the
subsequent organ angiogenesis. Here, we demonstrate that during development of the liver, which is an endodermderivative, a subset of
ECs is generated from FOXA2+ endoderm-derived fetal hepatoblast progenitor cells expressing KDR (VEGFR2/FLK-1). Using human and
mouse embryonic stem cell models, we demonstrate that KDR+FOXA2+ endoderm cells developing in hepatic differentiation cultures
generate functional ECs. This introduces the concept that ECs originate not exclusively from mesoderm but also from endoderm, sup-
ported in Foxa2 lineage-tracing mouse embryos by the identification of FOXA2+ cell-derived CD31+ ECs that integrate the vascular
network of developing fetal livers.INTRODUCTION
In early development, endothelial cells (ECs) emerge from
mesodermal progenitors and initiate vasculogenesis to
form the extraembryonic yolk sac vasculature and the
embryonic primary vascular plexus. Subsequently, these
vascular systems are rapidly expanded and remodeled.
This process is termed ‘‘angiogenesis’’ and involves endo-
thelial sprouting, vessel branching, and intussusception
from existing blood vessels (Patan, 2004). Hepatic blood
vessels consist of the hepatic artery and three types of
venous vessels (the portal veins, hepatic veins, and sinu-
soids) that differentiate as the liver bud expands around
embryonic day 10.5 (E10.5) in the mouse embryo. Based
on the position of the hepatic vessels and differential
expression of connexins and the NOTCH ligand Jagged1,
the origin of the hepatic endothelium was proposed to be
the adjacent vasculature, including omphalomesenteric
veins for the portal veins (Shiojiri et al., 2006), the cardinal
vein and the sinus venosus for the hepatic veins (Shiojiri
et al., 2006), and the omphalomesenteric and cardinal
veins for the sinusoids (Sugiyama et al., 2010). Although in-
terpretations from studies seeking to define the precise or-
igins of the hepatic vasculature differ, the dogma is that
the hepatic endothelium is of mesodermal origin.
We provide evidence that fetal hepatic ECs also originate
from a hepatic endoderm progenitor that expresses the
vascular endothelial growth factor (VEGF) receptor KDR
(VEGFR2/fetal liver kinase 1). Our previous work revealed
the existence of KDR-expressing hepatic progenitors
(KDR+ progenitor) in human embryonic stem cell (hESC)556 Stem Cell Reports j Vol. 3 j 556–565 j October 14, 2014 j ª2014 The Acultures differentiated toward the hepatic lineage (Gold-
man et al., 2013). Isolated hESC-derived endoderm cells
give rise to both the KDR+ hepatic progenitors and the
committed KDR hepatic cells. A subset of ECs coexpress-
ing KDR and the endothelial marker CD31 (platelet endo-
thelial cell adhesion molecule) consistently developed in
hepatic differentiated cultures. KDR+ progenitors are
conserved in the developing liver of the mouse because
they are present in E8.0 mouse anterior foregut endoderm,
confirmed by cell morphology and expression of the endo-
dermmarker FOXA2. Foregut endoderm cells coexpressing
KDR and FOXA2 generated in fetal livers a large subset of
progenitors for hepatocytes and cholangiocytes, the fetal
hepatoblasts, which in turn derived hepatocytes and chol-
angiocytes in adult livers. Here, we demonstrate that KDR+
hepatic progenitors are also an unexpected endoderm-
derived progenitor for ECs that develop concomitantly
with hepatic cells in human and mouse ESC hepatic differ-
entiation cultures. Two lineage-tracing studies in mice
tracking the fate of FOXA2-expressing cells provide in vivo
evidence for the EC fate of FOXA2+ cells in the developing
fetal liver, supporting the concept that ECs in the fetal liver
can also originate from an endoderm derivative.
RESULTS
Identification of Human ECs Generated from
hESC-Derived KDR+ Endoderm Cells and Human
Fetal Livers
Following induction with a high dose of Activin A in
embryoid body (EB) cultures, an enriched cell populationuthors
Figure 1. Generation of ECs from hESC-Derived KDR+ Endoderm Cells
(A) Flow analysis from day 5 EBs and day 9 hepatic cultures generated from the plated day 5 CXCR4+cKIT+KDR-PDGFRa (endoderm) cells.
All numbers reflect the mean ± SD for the number (‘‘n’’) of independent experiments (n = 5).
(B) Bright-field and FOXA2 IF image of day 5 endoderm cells cultured for 1 day (3200).
(C) Flow analysis at day 13 of K+C and KC cells purified at day 9 (n = 3).
(D) IF of day 9 K+C and KC populations 1 day after plating (3200).
(E) IF of day 9 KC, K+C, and K+C+ populations 4 days after plating (3200).
(F) qPCR analyses for HNF4a levels in day 5 endoderm population, and KC, K+C, and K+C+ populations cultured for 4 days (n = 4).
(G) Purification and expansion of K+C+ cells from day 9 K+C cells.
(H) IF of K+C+ cells cultured to day 17 (3200).
(I) qPCR analyses in day 5 endoderm population, and KC, K+C, and K+C+ populations cultured for 4 days (n = 4).
(J) Co-IF for CD31 and HNF4a on 7-week-old human fetal liver sections (3200). Arrows indicate cells coexpressing CD31 and HNF4a.
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negative for KDR and the mesendodermal marker
platelet-derived growth factor receptor a (PDGFRa) was
generated with high efficiency (Figure 1A). These cells
were isolated using fluorescence-activated cell sorting
(FACS) at day 5 of differentiation with purity above 95%
(Figure S1A available online). PDGFRa is expressed on
nearly all cells at day 4 of differentiation (Goldman et al.,
2013) but is completely downregulated by day 5 of differ-Stem Cellentiation (Figure 1A), so that the day 5 CXCR4+cKIT+ pop-
ulation is staged beyond mesendoderm development. To
verify purity of endoderm cells, immunofluorescence (IF)
staining for the endoderm marker FOXA2 was performed
after 1 day of culture. Endoderm cells formed clusters in
which each cell expresses FOXA2 (Figure 1B). In hepatic
media, the endoderm cells gave rise sequentially to hepatic
progenitors (KDR+CD31, hereafter termed ‘‘K+C’’), the
hepatic cells (KDR-CD31, hereafter termed ‘‘KC’’),Reports j Vol. 3 j 556–565 j October 14, 2014 j ª2014 The Authors 557
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(KDR+CD31+, hereafter termed ‘‘K+C+’’) (Figure 1A) (Gold-
man et al., 2013). The true identity of K+C hepatic pro-
genitors was shown by their ability following hepatic
maturation to support hepatitis C virus infection, a unique
feature for hepatocytes (Goldman et al., 2013).
To determine the origin of the K+C+ ECs, K+C progen-
itors and KChepatic cells were isolated at day 9 of differ-
entiation (Figure 1A) with purity always higher than 97%
(Figure S1B), cultured for 4 additional days in hepatic
media, and then evaluated for the generation of ECs based
on CD31 and KDR expression (Figure 1C). Only the K+C
cells were able to generate K+C+ ECs (Figure 1C).
To verify that ECs originate from endoderm-derived
K+C cells, we examined expression of hepatocyte nuclear
factor 4 a (HNF4a), themain transcription factor regulating
endoderm hepatic specification (Parviz et al., 2003), and
of the epithelial markers CK18 and CK19, which are ex-
pressed on human hepatoblasts (Roskams and Desmet,
2008). One day following the purification of day 9 K+C
cells, virtually all K+C cells expressed HNF4a (Figure 1D)
and both CK18 and CK19 (Figure S1C). Purified KC he-
patic cells served as positive control for the three markers
(Figures 1D and S1C). Comparison of HNF4a protein (Fig-
ure 1E) and transcript (Figure 1F) levels among purified
KC, K+C, and K+C+ populations cultured for 4 days
showed the highest and most homogeneous expression
of HNF4a protein in hepatic KC cells, whereas distribu-
tion of HNF4a protein becomes heterogeneous in K+C
progenitor cells and even more patchy in K+C+ ECs. Levels
of HNF4a transcript paralleled protein levels and indicated
highest levels in KC hepatic cells and lower similar
levels in K+C progenitors and K+C+ ECs. Although lower
than seen in KC cells, HNF4a levels in K+C and K+C+
populations were significantly higher than in day 5 endo-
derm cells. The presence of residual HNF4a in K+C+ ECs
further supports their endodermal origin.
The endothelial identity of K+C+ cells was supported by
expression of an additional endothelial marker, TIE2, eval-
uated as they emerged frompurified K+C cell populations
(Figure S1D). As the K+C cells differentiate into ECs, most
of the K+C+ ECs expressed TIE2. Moreover, all K+C+ cells
purified from cultured K+C cells (Figure 1G) coexpressed
the cytoplasmicmarker for ECmaturation, vonWillebrand
factor (vWF), and the cell surface markers CD31 and KDR
(Figures 1H and S1E). The endothelial phenotype of
K+C+ cells was stable because K+C+ cells continued to ex-
press CD31, KDR, and the endothelial marker CD144
(vascular endothelial [VE]-cadherin) following three pas-
sages (Figure S1F). Furthermore, high levels of transcripts
for the sinusoidal endothelial markers LYVE-1 and VEGFR3
(Ding et al., 2010; Nonaka et al., 2007) (Figure 1I) were
found in K+C+ cells as compared to KC and K+C pop-558 Stem Cell Reports j Vol. 3 j 556–565 j October 14, 2014 j ª2014 The Aulations. Homogeneous expression of LYVE1 protein in
K+C+ cells was confirmed, whereas the percentage of
K+C+ cells expressing VEGFR3 protein was low, indicating
discrepancy between transcript and protein levels for
VEGFR3 (Figure S1F). These molecular assays suggest a
more specialized sinusoidal phenotype of the endoderm-
derived K+C+ ECs.
To identify endoderm-derived ECs in early human devel-
opment, we searched human fetal liver specimens for ECs
that coexpressed CD31 and HNF4a, as characterized in
hESC cultures. We identified a few CD31+HNF4a+ ECs in
7- and 7.5-week-old fetal livers, which approximates the
developmental stage of hESC hepatic cultures (Figures 1J
and S1G–S1I). These double-positive cells suggest the pres-
ence of ECs derived from endoderm in developing human
fetal livers.
K+C+ ECs Derived from hESC-Derived KDR+
Endoderm Cells Are Functional In Vitro and In Vivo
We performed four well-established in vitro EC functional
assays (Goldman et al., 2009) to evaluate and compare
functionality of the purified K+C+ ECs generated from
hESC-derived endoderm cells to primary human umbilical
vascular ECs (HUVECs). K+C+ cells behaved similarly to
HUVECs in all assays. Their migratory rates were similar
in a wound-healing assay (Figure 2A). K+C+ cells incor-
porated acetylated low-density lipoprotein (ac-LDL) (Fig-
ure 2B) and formed tubes when placed into thick Matrigel
(Figure 2C). Finally, the vastmajority of K+C+ cells induced
vascular cell adhesion molecule (VCAM), intercellular
adhesion molecule (ICAM), and E-selectin membrane
expression following tumor necrosis factor a (TNF-a) stim-
ulation (Figures 2D and S2A).
To demonstrate in vivo functionality of K+C+ ECs, K+C
progenitors were transplanted into an injured muscle of
nonobese diabetic/severe combined immunodeficiency
mice that underwent femoral artery ligation inducing de
novo angiogenesis. An antibody against human CD31
(hCD31) was used to detect K+C+ ECs generated from the
transplanted K+C progenitors. Functionality of the
K+C+ ECswas assessed by the visualization of hCD31+ cells
integrated in the repaired host vessels by the presence of
GFP-labeled dextran present in all diffused functional ves-
sels. One week following K+C cell transplantation,
many hCD31+ cells were identified within diffused vessels
that were stained with dextran-GFP, indicating that the
K+C transplanted cells generated functional K+C+ ECs
in vivo (Figures 2E–2G, arrows). The human specificity of
the hCD31 antibody was confirmed by the absence of
staining of GFP-labeled dextranmouse ECs in control non-
transplanted injured muscle (Figure 2H). These data identi-
fied a subset of ECs that develop from the hESC-derived
KDR-expressing hepatic progenitor.uthors
Figure 2. In Vitro and In Vivo Functions of K+C+ ECs Generated from hESC-Derived K+C Progenitors
(A–D) Comparison of in vitro functions of K+C+ cells with HUVECs in a wound assay (3200) (A), incorporation of ac-LDL (3200) (B), tube
formation assay in Matrigel (3200) (C), and VCAM, ICAM, and E-Selectin expression analyzed by flow following TNF-a activation (n = 3
independent experiments) (D). IgG, immunoglobulin G.
(E–H) In vivo function of K+C+ cells generated from K+C cells transplanted into a femoral artery ligation injury mouse model. Dextran-
GFP was injected 5 min prior to sacrifice to visualize the functional diffused GFP+ vessels. IF for hCD31 1 week after cell transplantation is
shown. Arrows indicate the transplanted hCD31+ ECs that integrated the GFP host mouse vessels. Close-up pictures are from 3200.
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ESC-Derived KDR+ Endoderm Cells
To determine whether the development of ECs from an
endoderm progenitor was conserved in the mouse, we first
identified in vitro the emerging FOXA2+ endoderm cells
expressing KDR upon hepatic specification of an anteriorStem Cellprimitive streak-like mouse ESC-derived cell population.
The endodermprogramwas inducedwith a highdose of Ac-
tivin A using a dual-reporter mouse ESC line in which GFP
and human CD4 cDNAs were targeted to the Brachyury (T)
and Foxa2 loci, respectively (T-GFP, Foxa2-CD4) (Gouon-
Evans et al., 2006). At day 5 of differentiation, most of theReports j Vol. 3 j 556–565 j October 14, 2014 j ª2014 The Authors 559
Figure 3. Generation of ECs from Mouse ESC-Derived KDR+ FOXA2+ Endoderm Cells
(A) Illustration of the mouse ESC hepatic differentiation protocol. Flow analysis from day 5 and day 6 EBs (n = 3) is shown.
(B) IF at day 11 from K sorted cells and at day 9 from K+ sorted cells (3100).
(C) Relative transcript levels in day 5 EBs, day 6 EBs, K+ cells (at day 9), and K cells (at day 9 and 11) (n = 3 independent experiments).
Note that most y axes are in log scale.
(D) IF of K+ cells at day 9 of differentiation showing clusters of cells expressing both HNF4a and CD31 (3100, arrows).
(E) IF of HNF4a and CD31 of one GFP+ clone obtained from clonal assay of K+ cells (3200).
(F) Flow analysis of day 9 K+ cells (n = 3).
(G) Flow analysis for ICAM and CD144 expression of the K+ cells treated or not for 18 hr with TNF-a (n = 3).
(H) Images of ac-LDL incorporation by K+ cells (3200).
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high levels of Foxa2-CD4, indicative of anterior primitive
streak-like cells (Figure 3A), as previously shown (Gouon-
Evans et al., 2006). Following EB dissociation, cells were
subjected to reaggregation in the presence of Activin A to
maintain endoderm fate, bone morphogenetic protein 4
(BMP-4) and basic fibroblast growth factor (bFGF) to induce
hepatic specification, and VEGF to promote EC survival
(Gouon-Evans et al., 2006). One day later, most of the cells
maintained expression of Foxa2-CD4. To exclude potential
contamination with mesoderm and mesendoderm cells,560 Stem Cell Reports j Vol. 3 j 556–565 j October 14, 2014 j ª2014 The Athe T-GFP+ cells and PDGFRa+ cells, respectively, were
sorted out from the Foxa2-CD4+ cells that were subse-
quently analyzed for KDR expression. Among the Foxa2-
CD4+PDGFRa cells, a subset of cells expressed KDR
(7.9% ± 5%). Both Foxa2-CD4+PDGFRa-KDR cells (here-
after termed ‘‘K cells’’) and Foxa2-CD4+PDGFRa-KDR+
cells (hereafter termed ‘‘K+ cells’’) were purified by FACS
(Figure 3A) with purity greater that 95% for K cells and
higher than 85% for K+ cells. The latter were slightly
contaminated with Foxa2-CD4+ but not with Foxa2-CD4-
KDR+ cells (Figure S2B). Sorted cells were further cultureduthors
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Endoderm Derives Hepatic Endothelial Cellsto evaluate their hepatic and endothelial fate capacity by
IF (Figures 3B and S2C) and quantitative PCR (qPCR)
(Figure 3C).
K cells maintained expression of FOXA2 following
5 days of culture and began to express a-fetoprotein
(AFP), one of the first markers indicative of hepatic specifi-
cation (Figure 3B). In contrast, FOXA2 was less expressed,
and AFP protein was almost absent in differentiated K+
cell cultures (Figure 3B). CD31 was much more abundant
in K+ cell cultures than in K cultures. Thus, K+ cells
have a propensity to specify into ECs and the K cells
into hepatic cells. These distinct fates of the K and K+
populations were confirmed by qPCR analyses (Figure 3C).
Afp transcript levels were detected in day 6 endoderm EBs
following hepatic specification of the day 5 anterior prim-
itive streak-like cells as expected. These levels were strongly
upregulated over time in purified K cells. The endoderm
Foxa2 transcript levels decreased with time as both purified
populations differentiate. It is noteworthy that Foxa2 tran-
script levels were similar at day 9 of differentiation in both
K and K+ populations, although FOXA2 protein was pref-
erably expressed in K hepatic cultures, reminiscent of the
endoderm origin of CD31+ ECs derived fromK+ cells. Simi-
larly, levels of Hnf4a are detected in day 9 K+ cultures that
are mainly composed of CD31+ ECs. Levels of Hnf4a
decreased by only 50% as compared to those from day 11
K cultures mainly composed of hepatic cells. Consistent
with the hepatic identity of the K cells, levels of the
epithelial marker EpCAM remained similar in K differen-
tiated cells to those found in day 5 endoderm progenitors
and day 6 endoderm population. However, these levels
decreased dramatically in differentiated K+ cells and were
inversely correlated with levels of the endothelial markers
Kdr,CD31, andCD144 (VE-Cadherin), supporting the endo-
thelial potential of the K+ cells. Similar to the human endo-
derm-derived ECs, the mouse ECs derived from the K+ cells
are highly enriched for the sinusoidal endothelial markers
Lyve-1, Vegfr3, and Stabilin, suggesting the sinusoidal iden-
tity of these ECs.
IF for HNF4a and CD31 on day 9 differentiated K+ cells
confirmed the qPCR data (Figures 3D and S2D). K+ cells
derived both HNF4a+ hepatic endoderm cells and CD31+
ECs. Most interestingly, we found clusters of cells coex-
pressing HNF4a and CD31 (Figure 3D, arrows), implying
the bipotential fate of K+ cells to differentiate into both he-
patic endoderm and the endothelial lineage.
To provide definitive evidence for the endothelial fate of
K+ endoderm cells, a clonal assaywas used to show that sin-
gle K+ endoderm cells give rise to both HNF4a+ hepatic
endoderm cells and CD31+ ECs. In this assay, HNF4a was
used as a marker because it is not expressed in ECs but
strictly activated in the liver bud epithelium (Parviz et al.,
2003). An antibody against HNF4a excluded any misinter-Stem Cellpretation of the committed endoderm cells. Single GFP+K+
cells were isolated at day 6 of differentiation and cocultured
with non-GFP-tagged endoderm cells to provide the GFP-
tagged K+ cells an appropriate environment for cell survival
and differentiation. Out of 768 wells plated with single
cells, 233 contained a GFP+ clone following 3 days of cul-
ture (Figures S2E and S2F). Of the GFP+ colonies, 80.3%
expressed the endothelial marker CD31, supporting the
endothelial fate of K+ endoderm cells. Of the GFP+ col-
onies, 4.3% contained HNF4a+ hepatic endoderm cells,
consistent with the endoderm origin of K+ cells. Most
importantly, 2.6% of GFP+ clones were composed of both
CD31+ ECs and HNF4a+ hepatic endoderm cells (Figures
3E, S2E, and S2F), validating the endoderm origin of the
CD31+ ECs derived from K+ endoderm cells. Within these
GFP+ clones, we identified a few cells that coexpressed
HNF4a and CD31 (Figure 3E), supporting further the endo-
derm origin of the K+ cell-derived ECs.
Flow cytometry (flow) analyses confirmed the endothe-
lial phenotype of the K+ differentiated cells and showed
that following 3 days of culture, the K+ cells generated on
average 25% of ECs that coexpressed KDR with CD31,
CD144, TIE2, or VEGFR3 (Figure 3F).Membrane expression
of LYVE1 by 3% of K+ cells was confirmed by flow (Fig-
ure 3F) and IF (Figure S2G).
To evaluate functionality of the K+ population-derived
ECs, we performed the four in vitro functional assays
described above for human ECs. The vast majority of
CD144+ ECs induced ICAM expression following TNF-a
stimulation (Figure 3G). They showed the ability to uptake
ac-LDL (Figure 3H), migrate in a wound-healing assay (Fig-
ure S2H), and form tube-like structures in Matrigel (Fig-
ure S2I). Because differentiated K+ cell cultures were not
solely composed of CD31+ ECs, the EC identity of the
migrating cells was confirmed by IF for CD31 in the
wound-healing (Figure S2H) and Matrigel (Figure S2I) as-
says. Similar to the human system, mouse ESC-derived
endoderm gives rise to ECs from a KDR+FOXA2+-express-
ing progenitor cell.
FOXA2+ Cells Contribute In Vivo to the Development
of a Subset of ECs in Mouse Fetal Livers
We next probed the existence of FOXA2+ endoderm cell-
derived ECs using a Foxa2 lineage-tracing mouse model,
obtained by crossing the heterozygous Foxa2-iCre mouse
(Horn et al., 2012) with the homozygous reporter-
enhanced yellowfluorescent protein (YFP)mouse, inwhich
YFP is ubiquitously expressed under the Rosa26 promoter,
only after Cre recombinase excises the STOP cassette
flanked by LoxP sites (Srinivas et al., 2001). The Foxa2-
iCre mice faithfully mark cells that express FOXA2 from
the anterior primitive streak of E7.5 embryos, in foregut,
hindgut, and midgut endoderm, as well as in the heart,Reports j Vol. 3 j 556–565 j October 14, 2014 j ª2014 The Authors 561
Figure 4. FOXA2+ Cell Contribution to Fetal Liver ECs in Two Foxa2 Lineage-Tracing Mouse Models
(A–C) IF of fetal liver sections from E12.5 YFPpos embryos of Foxa2-iCre;YFP mice (3200). White arrows indicate the YFP+CD31+ ECs, and
yellow arrowheads indicate the YFP-CD31+ hematopoietic cells.
(D) Flow analyses from four E13.5 YFPpos fetal livers and one E13.5 YFPneg fetal liver of Foxa2-iCre;YFP mice. Numbers indicate the mean ±
SD of the percentage of cell populations in each gate for four YFPpos embryos.
(E) FOXA2 and YFP IF on E8.5 embryo section of Foxa2-CreTAM;YFP mice. Large image shows the tiling of a whole E8.5 embryo. The small
image is a close-up of the foregut endoderm (3100).
(F) IF of YFP and KDR at E8.5 of Foxa2-CreTAM;YFP mice (3200). White arrows indicate rare YFP+KDR+ cells.
(G–I) IF for YFP and CD31 of E12.5 fetal liver sections from Foxa2-CreTAM;YFP mice (3200). White arrows indicate few YFP+CD31+ ECs.
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in E9.5 embryos (Horn et al., 2012).
Despite the broad expression of FOXA2 in early embryo-
genesis, YFP marks specifically FOXA2+ hepatoblasts (Fig-
ure S3A, dotted area) that are positive for AFP (Figure S3B,
consecutive section of A, dotted area) and unspecified fore-
gut endoderm cells (Figure S3A, arrow) as the liver bud
develops. The presence of FOXA2 protein in E9.5 liver
buds was accurately recapitulated by YFP IF (Figure S3A)
revealing the high FOXA2 tracking efficiency. To investi-
gate the contribution of FOXA2+ cells to the endothelial
lineage, co-IF for CD31 and YFP was performed on sections
from E9.5 liver buds when hepatoblasts began to inter-
mingle with ECs. Most of the CD31+ ECs were negative562 Stem Cell Reports j Vol. 3 j 556–565 j October 14, 2014 j ª2014 The Afor YFP suggesting their mesodermal origin, although rare
CD31+YFP+ cells were detected (Figures S3C–S3E arrows).
In contrast, because the fetal liver expanded further at
E12.5, many YFP+ CD31+ ECs were visualized (Figures
4A–4C, 20 arrows). Most of these YFP+ ECs were evenly in-
tegrated to the hepatic endothelial network,most likely the
primitive sinusoids that are well established at that time. IF
for AFP on consecutive slides indicated that all YFP+CD31+
cells were negative for AFP, confirming their committed
endothelial phenotype (Figures S3B–S3E for E9.5, and Fig-
ures S3F–S3I for E12.5). The identity of the FOXA2+ cell-
derived ECs was supported by the detection of YFP+KDR+
cells integrated into the E12.5 liver vasculature network
(Figures S3J–S3L).uthors
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patic and EC populations, flow analyses were performed
for coexpression of YFP with the hepatic cell surfacemarker
Delta-like 1 homolog (DLK)/Pref-1 (Tanimizu et al., 2003)
and endothelial markers CD31, KDR, and CD144 in disso-
ciated E13.5 fetal livers (Figures 4D and S4A). The vast ma-
jority of DLK+ hepatoblasts was positive for YFP indicating
efficient lineage tracing. About 15% of the CD144+KDR+
EC population within E13.5 fetal livers was YFP+, support-
ing the endoderm origin of this subset of ECs. The remain-
ing 85% of the total EC population was negative for YFP,
consistent with a mesodermal origin of these ECs. CD31
expression confirmed the presence of YFP+ ECs, although
with a lower percentage than those from the CD144 or
KDR populations (5.92% ± 1.5%). This was expected
because CD31 also marks some hematopoietic cells in
mouse fetal livers that appeared on E12.5 fetal liver sections
as round cells with weaker expression for CD31 (Figures
4A–4C, arrowheads) and as a CD31low population on flow
plots (Figure 4D). The Foxa2 lineage-tracing mouse study
supports the existence of a subset of ECs derived from
endoderm cells within the developing fetal liver.
Because Foxa2 is not solely restricted to endoderm in
early embryogenesis, we further demonstrated the endo-
derm origin of a subset of hepatic fetal ECs using a more
restrictive mouse model for fate mapping FOXA2+ endo-
derm cells: the tamoxifen-inducible Foxa2-CreTAM line
(Park et al., 2008). Injection of a single dose of tamoxifen
at E6.75 resulted in tracking specifically FOXA2+ endo-
derm cells at E8.5 (Figures 4E and S4B) and hepatoblasts
of the liver bud at E9.5 (Figures S4C and S4D) excluding
tracing of any mesodermal derivatives. In this mouse
model, a few KDR+YFP+ endoderm cells were found in
E8.5 within the foregut endoderm (Figures 4F and S4B)
and may represent progenitors for the endoderm-derived
ECs observed at later stages. Rare YFP+ ECs coexpressing
either CD31 or KDR were detected in E9.5 liver buds (Fig-
ures S4E and S4F, two arrows), whereas theywere numerous
in the E12.5 fetal liver (Figures 4G–4I and S4G–S4J, arrows).DISCUSSION
We provide evidence that endoderm-derived progenitors
contribute to a subpopulation of hepatic ECs in the devel-
oping liver. The endoderm-derived ECs intermingle with
themesoderm-derived ECnetwork developed by angiogen-
esis from the initial primitive vascular plexus.We identified
the endoderm-derived endothelial progenitors by expres-
sion of the endodermmarker FOXA2 and the cell surface re-
ceptor KDR in both human and mouse ESC differentiation
cultures. Lineage-tracing studies in the mouse embryo
demonstrated that KDR is expressed not only on vascularStem Celland hematopoietic progenitors but also on a broad spec-
trum of other mesodermal progenitors that give rise to car-
diac and skeletal muscle cells (Ema et al., 2006; Motoike
et al., 2003). Other studies redefined the KDR-expressing
cell as a bipotent progenitor for endothelial and hemato-
poietic cells in mouse embryos and hESC cultures, identi-
fied as the hemangioblast (Huber et al., 2004; Kennedy
et al., 2007). Similarly, a bipotent KDR+ progenitor can
give rise to both ECs and cardiomyocytes in the developing
heart (Kattman et al., 2006; Yang et al., 2008). All these
KDR+ progenitors are of mesodermal origin. Our previous
study provided the first evidence for the existence of a
KDR+ progenitor for liver, an endoderm derivative (Gold-
man et al., 2013). Given the well-documented studies on
the bipotentiality of a KDR+ progenitor for the EC lineage
and mesodermal derivatives, it should perhaps not be sur-
prising that we were able to document the bipotentiality
of an endoderm-derived KDR+ progenitor for hepatic
endoderm cells and ECs using clonal assays. Similar to
the hemangioblast or the bipotent endothelial-cardiomyo-
cyte progenitor, we demonstrated the ability of single
mouse KDR+FOXA2+ endoderm cells to give rise to both
HNF4a+ hepatic endoderm and CD31+ ECs. Detection of
CD31+ ECs coexpressing HNF4a frommouse and hESC he-
patic differentiation cultures and the developing human
fetal liver specimens further supports the existence of
endoderm-derived ECs in fetal liver development. The
inducible Foxa2 lineage-tracing studies verified the endo-
derm origin of a subset of hepatic ECs. In the future, in vivo
strategies may be capable of demonstrating the dynamic
transition of endoderm cells turning off endodermmarkers
and developing into hepatic ECs while turning on blood
vessel markers, in order to further confirm and define
mechanisms by which endoderm generates ECs. Alterna-
tively, single-cell RNA-sequencing studies might be used
to capture a molecular profile of endoderm cells that are
transitioning to an EC fate.
The functional specificity of ECs forming themicrocircu-
lation of organs has long been appreciated and recently
defined molecularly by Nolan et al. (2013). The character-
ization of the KDR+ endoderm cell-derived ECs generated
in mouse and hESC cultures suggests that those are the
specialized sinusoidal ECs of the fetal liver. Likewise, two
mesoderm-derived organs, the blood and heart, develop
their own ECs from a common KDR+ progenitor for he-
matopoietic cells or cardiomyocytes, respectively. It is
tempting to speculate that functional specificity of micro-
vascular ECs is committed very early during organogenesis
and ascribed to a common progenitor for the main cell
component of the organ and the specialized ECs. Previous
studies in blood and heart development and our work in
liver development would suggest that this common pro-
genitor expresses KDR. A deeper understanding of theReports j Vol. 3 j 556–565 j October 14, 2014 j ª2014 The Authors 563
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the fields of liver development and regeneration.EXPERIMENTAL PROCEDURES
Human and Mouse ESC Hepatic Differentiation and
Cell Sorting
hESCs (HES-2) were differentiated into the hepatic lineage as previ-
ously described (Goldman et al., 2013). At day 5 of differentiation,
CXCR4+cKIT+KDR-PDGFRa endoderm cells were isolated with a
FACSAria Cell Sorter (BD Biosciences) and cultured in hepatic me-
dia as previously defined (Han et al., 2011).
The mouse ESC line T-GFP/Foxa2-CD4 was described (Gouon-
Evans et al., 2006). ESCswere cultured at 30,000 cells/ml for EB for-
mation in serum-free differentiation (SFD) media (Gouon-Evans
et al., 2006). Day 2 EBs were dissociated, and cells (40,000 cells/
ml) were reaggregated in SFD media with Activin A (100 ng/ml;
PeproTech). Day 5 EBs were dissociated and reaggregated with
SFD media with Activin A (100 ng/ml), BMP-4 (10 ng/ml), VEGF
(10 ng/ml), and bFGF (10 ng/ml; Invitrogen). Day 6 aggregates
were dissociated with 0.25% trypsin/EDTA. Purified populations
were further cultured in hepatic media. All cytokines except Acti-
vin A and bFGF were purchased from R&D Systems.
Mice
The Foxa2 lineage-tracing mouse model was obtained by crossing
the heterozygous Foxa2-iCre mice (Horn et al., 2012) and the ho-
mozygous reporter Rosa26-loxPSTOPloxP-eYFP mice (Srinivas et al.,
2001). The inducible Foxa2-CreTAM mouse model was obtained
from Jackson Laboratory (stock number 008464) and crossed
with the YFP reporter mice. The use of mouse models in these ex-
periments received Institutional Animal Care and Use Committee
approval.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, four figures, and four tables and can be found with
this article online at http://dx.doi.org/10.1016/j.stemcr.2014.08.
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